Evidence map›Paper›PMID 38334687›Full record

ArticleParasite (Paris, France)2024

Comparative performance of ISAGA IgM and ELISA assays for the diagnosis of maternal and congenital Toxoplasma infections: which technique could replace ISAGA IgM?

Anne-Sophie Deleplancque, Hélène Fricker-Hidalgo, Christelle Pomares, Coralie L'Ollivier, Jean-Philippe Lemoine, Bernard Cimon, Luc Paris, Sandrine Houzé, Isabelle Villena, Hervé Pelloux and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Parasite (Paris, France), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. La Tunisie medicale · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Anne-Sophie DeleplancqueCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - CHU Lille, Parasitology Mycology Department, INSERM U1285, CNRS UMR 8576, Glycobiology in Fungal Pathogenesis and Clinical Applications, Université de Lille, Lille, France.
Hélène Fricker-HidalgoCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Laboratory of Parasitology and Mycology, Grenoble Alpes University Hospital and Institute for Advanced Biosciences, Grenoble Alpes University, INSERM U1209, CNRS UMR5309, Grenoble, France.
Christelle PomaresCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Parasitology-Mycology laboratory, Côte d'Azur University, INSERM 1065, Nice University Hospital, Nice, France - Centre Méditerranéen de Médecine Moléculaire (C3 M), U1065, Université Côte d'Azur, INSERM, Archimed Building, 151 route Saint Antoine de Ginestière, Nice, France.
Coralie L'OllivierCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - IHU-Méditerranée Infection, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, France - Aix Marseille University, IRD, AP-HM, SSA, VITROME, IHU Méditerranée, Marseille, France.
Jean-Philippe LemoineLaboratoire de Parasitologie-Mycologie, CHU d'Angers, Angers, France.
Bernard CimonCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Laboratoire de Parasitologie-Mycologie, CHU d'Angers, Angers, France - Angers University, Brest University, IRF, SFR 4208 ICAT, Angers, France.
Luc ParisCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Parasitology laboratory, AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
Sandrine HouzéCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Parasitology laboratory, AP-HP, Hôpital Bichat - Claude Bernard, Paris, France - University of Paris Cité, IRD 261, MERIT, Paris, France.
Isabelle VillenaCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Department of Parasitology and Medical Mycology, National Reference Centre on Toxoplasmosis, Reims Hospital, Reims, France - Team EA 7510, SFR CAP-SANTE, Reims Champagne Ardenne University, Reims, France.
Hervé PellouxCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Laboratory of Parasitology and Mycology, Grenoble Alpes University Hospital and Institute for Advanced Biosciences, Grenoble Alpes University, INSERM U1209, CNRS UMR5309, Grenoble, France.
Odile VillardCentre National de Référence Toxoplasmose - Pôle Sérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - Institut de Parasitologie et de Pathologie Tropicale, UR7292 Dynamique des Interactions Hôte-Pathogène, Fédération de Médecine Transrationnelle, Université de Strasbourg, Strasbourg, France - Laboratoire de Parasitologie et Mycologie Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Hôpitaux Universitaires de Strasbourg · FRInserm · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Reims · FRCentre National de la Recherche Scientifique · FRInstitut de Recherche pour le Développement · FRSorbonne Université · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ISAGA immunocapture test for the detection of anti-Toxoplasma immunoglobulin M is a manual technique known for its excellent sensitivity and specificity. The purpose of this retrospective, multicenter study was to compare the performances and agreement between ISAGA and other IgM detection techniques before cessation of ISAGA production. The analytic performance of the different tests was evaluated using 1,341 serum samples from adults with positive IgM and negative IgG to Toxoplasma gondii, and 1,206 sera from neonates born to mothers with seroconversion. The agreement between the tests was evaluated on 13,506 adult and 5,795 child serum samples. The sensitivity of Toxo-ISAGA IgM

Indexed as

ToxoplasmaToxoplasmosisToxoplasmosis, CongenitalAdultAntibodies, ProtozoanChildEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin MInfant, NewbornRetrospective StudiesAntibodies, ProtozoanImmunoglobulin MIgM detectionISAGA IgM®SensitivitySpecificityToxoplasmosis

Identifiers

PMID38334687
PMCPMC10854481
OpenAlexW4391695721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.